Untreated sleep apnea quietly damages nearly every major system in your body. In a 14-year follow-up study, people with moderate-to-severe sleep apnea had a 33% mortality rate, compared to roughly 7% in people without the condition. The damage accumulates gradually, driven by repeated drops in oxygen levels and constant sleep disruption, night after night, for years.
How Untreated Sleep Apnea Damages Your Body
Every time your airway collapses during sleep, your blood oxygen level drops. This can happen dozens or even hundreds of times per night. Each episode triggers a stress response: your heart rate spikes, your blood pressure surges, and your brain partially wakes you up to restart breathing. You usually don’t remember these arousals, but they prevent you from reaching the deeper stages of sleep your body needs for repair.
The repeated oxygen drops create a cycle of oxidative stress at the cellular level. Unstable molecules called free radicals build up and damage the lining of your blood vessels, making them stiffer and more prone to plaque buildup. This vascular damage is the thread connecting sleep apnea to heart disease, stroke, cognitive decline, and metabolic problems. It’s not just about being tired, though the exhaustion is real. The oxygen swings are silently reshaping your cardiovascular and metabolic health while you sleep.
Heart Disease and High Blood Pressure
The link between untreated sleep apnea and high blood pressure is one of the strongest in sleep medicine. People who declined treatment or couldn’t use it had roughly double the risk of developing new-onset hypertension compared to people without the condition, based on a large study published in JAMA. Those who used CPAP therapy consistently actually had a lower risk of hypertension than the general population.
The cardiovascular risks go beyond blood pressure. People with obstructive sleep apnea are about 2.2 times more likely to develop atrial fibrillation, an irregular heart rhythm that raises the risk of stroke and heart failure. In people under 65, the severity of nighttime oxygen drops was an even stronger predictor of atrial fibrillation than the diagnosis of sleep apnea alone. The worse the oxygen dips, the higher the risk.
Type 2 Diabetes and Weight Gain
Sleep apnea and type 2 diabetes feed each other in a vicious cycle. Severe sleep apnea (30 or more breathing interruptions per hour) is associated with a 71% higher risk of developing diabetes compared to people without the condition. Even moderate sleep apnea carries a meaningful increase. The connection runs through insulin resistance: fragmented sleep and low oxygen levels impair your body’s ability to regulate blood sugar, even if your weight stays the same.
Weight management becomes harder too. People with untreated sleep apnea have significantly higher levels of leptin, a hormone that normally signals fullness. That sounds like it would reduce appetite, but chronically elevated leptin leads to leptin resistance, meaning your brain stops responding to the “full” signal. The result is increased hunger and cravings, particularly for high-calorie foods, making it harder to lose weight. And since excess weight worsens sleep apnea, the cycle tightens.
Cognitive Decline and Dementia Risk
Your brain is especially vulnerable to the oxygen deprivation caused by untreated sleep apnea. A meta-analysis of over 212,000 participants found that adults with sleep apnea were 26% more likely to develop significant cognitive decline or dementia over follow-up periods of 3 to 15 years. In one study of women in their early 80s, those with sleep apnea had a higher risk of progressing to mild cognitive impairment or dementia within five years, and the risk tracked directly with how severely their oxygen levels dropped at night.
The mechanism appears to involve the same protein plaques found in Alzheimer’s disease. People with untreated sleep apnea show signs of increased amyloid plaque and tau protein accumulation in the brain. Deep sleep is when your brain clears these waste proteins, and sleep apnea prevents you from spending enough time in those restorative stages. Postmortem studies have also found that people with more severe nighttime oxygen drops had more micro-infarcts (tiny areas of dead tissue) in their brains, along with neuronal loss in a region critical for attention and arousal.
Sleep apnea has also been linked to an earlier age of onset for Alzheimer’s disease and mild cognitive impairment, suggesting that it doesn’t just increase risk but accelerates the timeline.
Liver Damage
Untreated sleep apnea is independently associated with the development and progression of non-alcoholic fatty liver disease, even after accounting for obesity and other shared risk factors. The key driver appears to be the severity of oxygen drops during sleep. People with severe sleep apnea show signs of significant liver fibrosis (scarring), which is the stage where fatty liver disease starts causing lasting damage. Since fatty liver disease often has no symptoms until it’s advanced, sleep apnea can push it forward silently.
Driving and Daily Safety
Drowsy driving is one of the most immediate and dangerous consequences of untreated sleep apnea. A systematic review and meta-analysis found that drivers with sleep apnea have roughly 2.4 times the risk of a motor vehicle crash compared to drivers without it. Studies of commercial truck drivers found a two-fold higher crash rate per mile among those with undiagnosed sleep-disordered breathing.
The danger extends beyond the road. Excessive daytime sleepiness affects concentration, reaction time, and decision-making in every context, from operating machinery to managing complex tasks at work. About one-third of people with sleep apnea experience chronic morning headaches, a symptom that compounds the fatigue and makes the first hours of the day especially difficult.
Long-Term Survival
The Busselton Health Study tracked people with and without sleep apnea over 14 years. Among those with moderate-to-severe sleep apnea, one in three had died by the end of the follow-up period. In comparison, mortality was around 7% for both people with mild sleep apnea and people without it. That’s a striking gap, and it held even in a relatively small study group.
The excess deaths were driven largely by cardiovascular causes, consistent with the vascular damage that accumulates from years of intermittent oxygen deprivation. Multiple studies have shown that consistent treatment of severe sleep apnea reduces cardiovascular mortality compared to no treatment. The implication is clear: the risks from untreated sleep apnea are not fixed. They respond to intervention, and the earlier treatment starts, the less cumulative damage occurs.